Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)

Pingtan Marine Enterprise Ltd. (NASDAQ:PME) announced that the Company has declared a cash dividend of $0.01 per share of common stock outstanding, payable in cash on or about February 18, 2015 to shareholders of record on January 22, 2015. This marks the second consecutive quarterly dividend paid by the Company, which it intends to continue paying on a quarterly basis. Pingtan Marine Enterprise Ltd. (NASDAQ:PME) … Continue reading Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)

Investors Alert – Yahoo! (NASDAQ:YHOO) , Reynolds American (NYSE:RAI) , CNO Financial (NYSE:CNO) , Endo International PLC (NASDAQ:ENDP) , Ennis (NYSE:EBF)

Yahoo Inc. (NASDAQ:YHOO) said Monday it would buy mobile analytics startup Flurry Inc. for a reported $300 million, with teams from Weil Gotshal & Manges LLP and Goodwin Proctor LLP advising on either side of the deal. Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.96% in last session and finished the day at $33.60. Traded volume was 18.16million shares in the last session and the average … Continue reading Investors Alert – Yahoo! (NASDAQ:YHOO) , Reynolds American (NYSE:RAI) , CNO Financial (NYSE:CNO) , Endo International PLC (NASDAQ:ENDP) , Ennis (NYSE:EBF)

Johnson & Johnson (NYSE: JNJ) has inked a global licensing deal with the privately held Aduro BioTech for developing new therapies to treat prostate cancer. According to the oncology deal, the private company granted Janssen Biotech, a division of Johnson & Johnson, the exclusive license to certain candidates specifically engineered for the treatment of prostate cancer on the basis of Aduro’s proprietary live-attenuated double-deleted (LADD) … Continue reading Healthcare Active Stocks: Johnson & Johnson (NYSE:JNJ), Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)

Equities researchers at Stifel Nicolaus decreased their target price on shares of LinkedIn Corp (NYSE:LNKD) from $240.00 to $175.00 in a research report issued on Monday, Analyst Ratings News reports. Stifel Nicolaus’ price target would suggest a potential upside of 18.51% from the company’s current price. LinkedIn Corp (NYSE:LNKD) stock performance was -1.43% in last session and finished the day at $145.56. Traded volume was … Continue reading Notable Stocks: LinkedIn Corp (NYSE:LNKD), Yelp Inc (NYSE:YELP), Endo International PLC (NASDAQ:ENDP), National Bank of Greece (ADR) (NYSE:NBG), Barclays (NYSE:BCS)